BioSim Pharmaceuticals

BioSim Pharmaceuticals was a Seattle-based specialty biopharmaceutical company focused on developing a portfolio of hard-to-copy generic drugs and biologics, primarily for the orphan disease market. The company's lead program was a biosimilar version of H.P. Acthar Gel (adrenocorticotropic hormone), targeting indications such as infantile spasms and rare autoimmune disorders. BioSim aimed to lower healthcare costs by providing affordable alternatives to high-priced specialty biopharmaceuticals. Although the company was active in the mid-2010s and attended major industry conferences like JP Morgan Healthcare, it appears to have become inactive or defunct, with no significant updates to its pipeline or business operations reported after 2018.